Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1996 Sep;70(9):6463–6467. doi: 10.1128/jvi.70.9.6463-6467.1996

Interaction of the adenovirus L1 52/55-kilodalton protein with the IVa2 gene product during infection.

K E Gustin 1, P Lutz 1, M J Imperiale 1
PMCID: PMC190681  PMID: 8709283

Abstract

The adenovirus L1 52/55-kDa protein is expressed both in the early and late stages of infection, raising the possibility that it has multiple roles in the viral life cycle. To obtain possible insights into these roles, the yeast two-hybrid system was used to examine the interactions of the 52/55-kDa protein with viral and cellular factors. cDNA expression libraries from human 293 cells at both early and late stages of adenovirus type 5 infection were constructed and screened, with the 52/55-kDa protein being used as bait. Characterization of positive clones revealed that the adenovirus IVa2 gene product interacted specifically with the 52/55-kDa protein. In addition, the IVa2 protein was shown to interact with a bacterial glutathione S-transferase-52/55-kDa fusion protein in vitro, further supporting the finding with the yeast two-hybrid system. Finally, coimmunoprecipitation studies confirmed that the 52/55-kDa protein and IVa2 polypeptide interact specifically during the course of adenovirus infection. A potential role for the IVa2-52/55-kDa protein interaction in the regulation of transcription from the major late promoter and in viral assembly is discussed.

Full Text

The Full Text of this article is available as a PDF (396.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akusjärvi G., Persson H. Controls of RNA splicing and termination in the major late adenovirus transcription unit. Nature. 1981 Jul 30;292(5822):420–426. doi: 10.1038/292420a0. [DOI] [PubMed] [Google Scholar]
  2. Aleström P., Akusjärvi G., Perricaudet M., Mathews M. B., Klessig D. F., Pettersson U. The gene for polypeptide IX of adenovirus type 2 and its unspliced messenger RNA. Cell. 1980 Mar;19(3):671–681. doi: 10.1016/s0092-8674(80)80044-4. [DOI] [PubMed] [Google Scholar]
  3. Baker C. C., Ziff E. B. Promoters and heterogeneous 5' termini of the messenger RNAs of adenovirus serotype 2. J Mol Biol. 1981 Jun 25;149(2):189–221. doi: 10.1016/0022-2836(81)90298-9. [DOI] [PubMed] [Google Scholar]
  4. Binger M. H., Flint S. J. Accumulation of early and intermediate mRNA species during subgroup C adenovirus productive infections. Virology. 1984 Jul 30;136(2):387–403. doi: 10.1016/0042-6822(84)90175-2. [DOI] [PubMed] [Google Scholar]
  5. Crossland L. D., Raskas H. J. Identification of adenovirus genes that require template replication for expression. J Virol. 1983 Jun;46(3):737–748. doi: 10.1128/jvi.46.3.737-748.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Estojak J., Brent R., Golemis E. A. Correlation of two-hybrid affinity data with in vitro measurements. Mol Cell Biol. 1995 Oct;15(10):5820–5829. doi: 10.1128/mcb.15.10.5820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Feldman L. A., Rapp F. Inhibition of adenovirus replication by 1-beta-D-arabinofuranosylcytosine. Proc Soc Exp Biol Med. 1966 May;122(1):243–247. [PubMed] [Google Scholar]
  8. Fraser N., Ziff E. RNA structures near poly(A) of adenovirus-2 late messenger RNAs. J Mol Biol. 1978 Sep 5;124(1):27–31. doi: 10.1016/0022-2836(78)90145-6. [DOI] [PubMed] [Google Scholar]
  9. Guan K. L., Dixon J. E. Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase. Anal Biochem. 1991 Feb 1;192(2):262–267. doi: 10.1016/0003-2697(91)90534-z. [DOI] [PubMed] [Google Scholar]
  10. Gyuris J., Golemis E., Chertkov H., Brent R. Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2. Cell. 1993 Nov 19;75(4):791–803. doi: 10.1016/0092-8674(93)90498-f. [DOI] [PubMed] [Google Scholar]
  11. Harris K. F., Christensen J. B., Imperiale M. J. BK virus large T antigen: interactions with the retinoblastoma family of tumor suppressor proteins and effects on cellular growth control. J Virol. 1996 Apr;70(4):2378–2386. doi: 10.1128/jvi.70.4.2378-2386.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hasson T. B., Ornelles D. A., Shenk T. Adenovirus L1 52- and 55-kilodalton proteins are present within assembling virions and colocalize with nuclear structures distinct from replication centers. J Virol. 1992 Oct;66(10):6133–6142. doi: 10.1128/jvi.66.10.6133-6142.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hasson T. B., Soloway P. D., Ornelles D. A., Doerfler W., Shenk T. Adenovirus L1 52- and 55-kilodalton proteins are required for assembly of virions. J Virol. 1989 Sep;63(9):3612–3621. doi: 10.1128/jvi.63.9.3612-3621.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lucher L. A., Symington J. S., Green M. Biosynthesis and properties of the adenovirus 2 L1-encoded 52,000- and 55,000-Mr proteins. J Virol. 1986 Mar;57(3):839–847. doi: 10.1128/jvi.57.3.839-847.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lutz P., Kedinger C. Properties of the adenovirus IVa2 gene product, an effector of late-phase-dependent activation of the major late promoter. J Virol. 1996 Mar;70(3):1396–1405. doi: 10.1128/jvi.70.3.1396-1405.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Nevins J. R., Wilson M. C. Regulation of adenovirus-2 gene expression at the level of transcriptional termination and RNA processing. Nature. 1981 Mar 12;290(5802):113–118. doi: 10.1038/290113a0. [DOI] [PubMed] [Google Scholar]
  17. Reich N. C., Sarnow P., Duprey E., Levine A. J. Monoclonal antibodies which recognize native and denatured forms of the adenovirus DNA-binding protein. Virology. 1983 Jul 30;128(2):480–484. doi: 10.1016/0042-6822(83)90274-x. [DOI] [PubMed] [Google Scholar]
  18. Shaw A. R., Ziff E. B. Selective inhibition of adenovirus type 2 early region II and III transcription by an anisomycin block of protein synthesis. Mol Cell Biol. 1982 Jul;2(7):789–799. doi: 10.1128/mcb.2.7.789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Tribouley C., Lutz P., Staub A., Kedinger C. The product of the adenovirus intermediate gene IVa2 is a transcriptional activator of the major late promoter. J Virol. 1994 Jul;68(7):4450–4457. doi: 10.1128/jvi.68.7.4450-4457.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Winter N., D'Halluin J. C. Regulation of the biosynthesis of subgroup C adenovirus protein IVa2. J Virol. 1991 Oct;65(10):5250–5259. doi: 10.1128/jvi.65.10.5250-5259.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. van Beveren C. P., Maat J., Dekker B. M., van Ormondt H. The nucleotide sequence of the gene for protein IVa2 and of the 5' leader segment of the major late mRNAs of adenovirus type 5. Gene. 1981 Dec;16(1-3):179–189. doi: 10.1016/0378-1119(81)90074-3. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES